The α-Amylase inhibitor plays an important role in lowering starch digestion and its effect is reflected in decreased postprandial plasma hyperglycemia and insulin levels, increased resistance of starch to digestion, and increased activity of the colorectal tract, as well as reduction in the glycemic index [12,59]. Here, INS is linked to Hyperglycemia.